Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Amortizatization of Intangibles (2021 - 2025)

Aligos Therapeutics (ALGS) has disclosed Amortizatization of Intangibles for 5 consecutive years, with $444000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles fell 28.16% year-over-year to $444000.0, compared with a TTM value of $2.2 million through Dec 2025, up 22.71%, and an annual FY2025 reading of $2.2 million, up 22.71% over the prior year.
  • Amortizatization of Intangibles was $444000.0 for Q4 2025 at Aligos Therapeutics, down from $839000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q4 2023 and bottomed at -$37000.0 in Q1 2021.
  • Average Amortizatization of Intangibles over 5 years is $356000.0, with a median of $316000.0 recorded in 2025.
  • The sharpest move saw Amortizatization of Intangibles soared 18500.0% in 2022, then tumbled 68.54% in 2024.
  • Year by year, Amortizatization of Intangibles stood at -$23000.0 in 2021, then surged by 1730.43% to $375000.0 in 2022, then surged by 189.6% to $1.1 million in 2023, then plummeted by 43.09% to $618000.0 in 2024, then fell by 28.16% to $444000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ALGS at $444000.0 in Q4 2025, $839000.0 in Q3 2025, and $589000.0 in Q2 2025.